Minimally Invasive Surgery Devices Market Summary
As per MRFR Analysis, the Minimally Invasive Surgery Devices Market was valued at 34.09 USD Billion in 2023 and is projected to grow to 57.2 USD Billion by 2035, reflecting a CAGR of 4.41% from 2025 to 2035. The market is driven by the increasing preference for less invasive procedures, technological advancements, and a growing aging population requiring surgical interventions.
Key Market Trends & Highlights
The market is witnessing significant trends driven by technological innovations and changing patient preferences.
- Minimally Invasive Surgery Devices Market is expected to reach 35.59 USD Billion in 2024.
- General Surgery is projected to dominate the application segment with a valuation of around 10.0 USD Billion in 2024.
- Robotic-assisted surgeries are anticipated to grow by over 20% annually, enhancing surgical accuracy.
- North America is expected to lead the market with a valuation of 15.0 USD Billion in 2024.
Market Size & Forecast
2023 Market Size: USD 34.09 Billion
2024 Market Size: USD 35.59 Billion
2035 Market Size: USD 57.2 Billion
CAGR (2025-2035): 4.41%
Largest Regional Market Share in 2024: North America.
Major Players
Key players include Conmed, Abbott Laboratories, Hologic, Zimmer Biomet, Intuitive Surgical, and Medtronic.
Key Minimally Invasive Surgery Devices Market Trends Highlighted
Due to a number of important market factors, the worldwide market for minimally invasive surgical instruments is expanding significantly. Patients' need for less invasive surgical techniques is driving market growth as they look for shorter recovery periods and less discomfort following surgery.
Technological developments like imaging systems and robots are also improving the accuracy and efficacy of minimally invasive procedures. Additionally, the incidence of chronic illnesses is rising, which increases the need for surgical procedures and propels the market's expansion.
There are several opportunities in the global market for minimally invasive surgery devices, especially in developing nations. Countries in Asia-Pacific and Latin America provide opportunities for market participants to investigate as healthcare infrastructure advances and access to cutting-edge medical technology expands.
Additionally, outpatient operations are becoming more popular, which supports the demand for economical and effective healthcare solutions and opens up new avenues for procedure and device innovation.
A change toward a more patient-centric approach is reflected in recent worldwide developments. This involves creating portable, easily navigable gadgets that make a variety of medical settings more accessible and user-friendly.
Furthermore, the way operations are conducted is changing as a result of the incorporation of AI and machine learning into surgical instruments, which improves patient safety and results. Â These patterns point to a future in which minimally invasive surgical methods will become increasingly more commonplace, marking a significant shift in the global healthcare industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Minimally Invasive Surgery Devices Market Drivers
Increasing Prevalence of Chronic Diseases
The Minimally Invasive Surgery Devices Market is significantly influenced by the rising prevalence of chronic diseases, which drives the demand for advanced surgical solutions. According to the World Health Organization (WHO), non-communicable diseases account for 71% of all deaths globally, with cardiovascular diseases, cancer, and diabetes pen being the leading contributors.
With a report indicating that cancer cases are projected to rise by 47% from 2020 to 2040, equivalent to approximately 27.5 million new cases annually, there is a clear and pressing need for minimally invasive procedures.
Organizations like the American Society of Clinical Oncology (ASCO) are actively promoting innovative treatments, supporting the expansion of minimally invasive surgery technologies. As healthcare systems progressively adopt these techniques to improve patient outcomes and enhance recovery times, the Minimally Invasive Surgery Devices Market is anticipated to experience robust growth.
Technological Advancements in Surgical Devices
The advancement of technology in surgical devices is a key driver for the Minimally Invasive Surgery Devices Market, with innovations leading to enhanced precision and efficacy. The introduction of robotic-assisted surgery systems has revolutionized surgical procedures, allowing for improved dexterity and reduced recovery times.
The FDA has been approving more robotic surgical systems, with an increase of over 35% in the past five years. Major companies, such as Intuitive Surgical and Medtronic, are at the forefront of these advancements, contributing significantly to the development of minimally invasive techniques.
The global adoption of these technologies is projected to continue increasing due to their ability to significantly decrease hospital stay durations, thus driving overall market expansion.
Growing Geriatric Population
The aging population globally is a major driver for the Minimally Invasive Surgery Devices Market, as elderly individuals are more susceptible to chronic conditions requiring surgical intervention. United Nations data indicates that the number of people aged 65 years or older is projected to reach 1.5 billion by 2050, which is more than double the figure in 2019.
This demographic shift necessitates the need for effective surgical options with minimal risks, as traditional surgeries often come with higher complication rates for older patients.
Organizations like the American Geriatrics Society are emphasizing the importance of adopting less invasive procedures to improve surgical outcomes, which will subsequently propel the market for minimally invasive devices forward.
Increased Healthcare Expenditure
Rising healthcare expenditure is another significant driver of growth in the Minimally Invasive Surgery Devices Market. According to the World Bank, global health expenditure has risen to approximately 10% of global GDP, which translates to $8.3 trillion.
This increase in spending directly correlates with the demand for advanced medical technologies, including minimally invasive devices that are often associated with lower overall costs due to shorter recovery times and decreased hospital stays.
Governments and healthcare providers are recognizing the long-term cost benefits of investing in minimally invasive technologies, leading to initiatives aimed at incorporating these devices into standard care practices, further facilitating market expansion.
Minimally Invasive Surgery Devices Market Segment Insights
Minimally Invasive Surgery Devices Market Application Insights
Within this market, General Surgery dominated with a valuation of 10.5 USD Billion in 2024 and is projected to increase to 16.25 USD Billion by 2035, signifying its majority holding due to its wide application across various surgical procedures and growing preference for less invasive techniques among surgeons and patients.
Cardiothoracic Surgery followed closely with a valuation of 7.2 USD Billion in 2024, projected to reach 11.2 USD Billion in 2035, highlighting the increasing complexities of heart and lung conditions and the need for advanced surgical interventions that minimize recovery time.
Gynecological Surgery was also a significant contributor to the market, valued at 8.25 USD Billion in 2024 and expected to grow to 12.5 USD Billion by 2035, reflecting an increased focus on women's health and the growing acceptance of minimally invasive approaches for various gynecological conditions.
Urological Surgery, with a valuation of 5.44 USD Billion in 2024 and a projection of 8.5 USD Billion in 2035, demonstrated steady growth owing to rising incidents of urological disorders and the preference for less invasive procedures that offer quicker recovery times and minimal complications.
Lastly, Orthopedic Surgery, valued at 4.2 USD Billion in 2024 and expected to reach 9.75 USD Billion by 2035, showcased its growth driven by advancements in surgical technology and increased demand for procedures addressing issues like joint pain and mobility improvements.
Overall, the application segment within the Minimally Invasive Surgery Devices Market was underscored by diverse surgical domains, reflecting the evolving landscape of surgical interventions that prioritized patient satisfaction, shorter recovery periods, and enhanced operational efficiency.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Minimally Invasive Surgery Devices Market Product Type Insights
Various product types contribute significantly to this expansion, including Endoscopes, Robotic Surgery Systems, Laparoscopic Surgical Instruments, Visualization Systems, and Access Devices. Endoscopes are essential for diagnosis and treatment, owing to their ability to minimize patient discomfort and recovery time, thus contributing to the rising preference for minimally invasive procedures.
Robotic Surgery Systems enhance precision in surgical operations, allowing surgeons to perform complex procedures with greater control, which is a key factor driving their adoption. Laparoscopic Surgical Instruments remain important due to their versatility in various surgical applications and efficiency in reducing hospital stays.
Visualization Systems provide critical imaging support that aids surgeons during procedures, improving outcomes significantly. Furthermore, Access Devices facilitate entry into the surgical site while minimizing tissue damage, which makes them crucial in maintaining patient safety.
Overall, the Minimally Invasive Surgery Devices Market segmentation by Product Type reveals a dynamic structure driven by technological advancements, rising demand for minimally invasive surgeries, and an increasing focus on improving patient care.
Minimally Invasive Surgery Devices Market End-use Insights
The Minimally Invasive Surgery Devices Market is witnessing significant growth, particularly driven by diverse applications across various end-use sectors. Hospitals play a crucial role in this landscape, as they typically possess the necessary infrastructure and resources to implement complex minimally invasive procedures, leading to improved patient outcomes and reduced recovery times.
Ambulatory Surgical Centers are also becoming increasingly prominent, providing convenient setting for outpatient procedures which not only enhances patient experience but also reduces healthcare costs. Specialty Clinics, focusing on specific medical niches, further emphasize the importance of tailored solutions, which have garnered patient trust and preference for minimally invasive options.
As the Minimally Invasive Surgery Devices Market segmentation continues to evolve, the significant demand in these end-use categories is expected to drive market growth, reflecting a shift towards more efficient, cost-effective healthcare solutions.
Furthermore, advancements in technology and favorable governmental regulations are likely to create new opportunities within these sectors, solidifying their importance in the overall market dynamics.
Minimally Invasive Surgery Devices Market Technology Insights
The Minimally Invasive Surgery Devices Market within the Technology segment is experiencing notable growth and evolution, reflecting an increasing preference for less invasive surgical options.
The segment encompasses advanced techniques such as Video-Assisted Thoracoscopic Surgery, which has become a preferred method due to its reduced recovery time and minimal scarring, making it advantageous for both patients and healthcare providers.
Additionally, Transcatheter Aortic Valve Replacement has gained traction, aligning with the growing demand for efficient cardiac procedures without open-heart surgery. Natural Orifice Transluminal Endoscopic Surgery is noteworthy as it represents the frontier of surgical innovation, utilizing natural body openings, thus eliminating visible incisions.
The Minimally Invasive Surgery Devices Market data reflects a shift towards these technologies as they enhance patient outcomes, reduce hospital stays, and lower overall healthcare costs. Moreover, advancements in imaging and robotics within this segment are driving market growth, with government bodies emphasizing the need for innovative surgical solutions to improve healthcare delivery globally.
Minimally Invasive Surgery Devices Market Regional Insights
The Regional segment of the Minimally Invasive Surgery Devices Market showcased distinctive characteristics across various regions, with North America leading significantly with a market valuation of 12.5 USD Billion in 2024 and projected to reach 20.0 USD Billion by 2035. This dominance was driven by advanced healthcare infrastructure and high adoption rates of innovative surgical technologies.
Europe followed closely, valued at 10.5 USD Billion in 2024 and anticipated to rise to 16.8 USD Billion in 2035, owing to robust regulatory frameworks and healthcare expenditure.
The Asia Pacific region held a market value of 8.0 USD Billion in 2024, expected to grow to 12.5 USD Billion by 2035, driven by rising healthcare accessibility and increasing awareness of minimally invasive procedures.
South America, while smaller, showed promising growth from 3.0 USD Billion in 2024 to 5.0 USD Billion in 2035, indicating a shift towards advanced surgical technologies in emerging markets. The Middle East and Africa, valued at 1.59 USD Billion in 2024 with a projection to 3.9 USD Billion by 2035, gradually adopted minimally invasive techniques, responding to evolving healthcare needs.
Overall, these insights reflected the diverse dynamics and significant growth potential within the Minimally Invasive Surgery Devices Market across the Regional landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Minimally Invasive Surgery Devices Market Key Players and Competitive Insights
The Minimally Invasive Surgery Devices Market is characterized by rapid advancements in medical technology and an increasing preference for less invasive surgical options among patients and healthcare professionals alike.
The competitive landscape is shaped by a diverse array of companies striving to innovate and enhance their product offerings. Key players focus on developing advanced surgical instruments, imaging systems, and robotic-assisted solutions that facilitate precise and efficient surgical procedures.
The market's growth is driven by factors such as rising healthcare expenditures, technological advancements, and an aging population that is increasingly susceptible to chronic diseases. Companies are investing heavily in research and development to create devices that improve patient outcomes and support faster recovery times.
The market is also witnessing strategic collaborations, partnerships, mergers, and acquisitions, which are essential for gaining market share and leveraging existing technologies.
Conmed Corporation stands out within the Minimally Invasive Surgery Devices Market thanks to its robust product portfolio and strong commitment to innovation. The company specializes in surgical instrumentation across various disciplines, including orthopedics, general surgery, and gynecology, making it a versatile player in the market.
Conmed Corporation has established a solid global presence, bolstered by its strategic marketing initiatives and a focus on customer-centric solutions. The company's strengths lie in its ability to consistently introduce cutting-edge technologies, enhancing surgical efficiency while prioritizing patient safety.
Furthermore, Conmed Corporation's dedication to training and education ensures that healthcare professionals effectively utilize its tools, ultimately contributing to improved surgical outcomes. This combination of innovation and strong market positioning allows Conmed Corporation to compete effectively in this dynamic landscape.
Stryker is another key player in the Minimally Invasive Surgery Devices Market, recognized for its commitment to advancing medical technology through high-quality products and services. Stryker offers a broad range of minimally invasive surgical devices, including robotic surgical systems, endoscopic cameras, and instruments for orthopedic surgery.
The company’s global presence is reinforced by a well-established distribution network and a diverse product line designed to cater to different surgical specialties. Stryker’s strengths lie in its robust research and development capabilities, allowing it to stay at the forefront of innovation.
Moreover, the company frequently engages in strategic mergers and acquisitions to expand its capabilities and market share in the minimally invasive segment. These endeavors have not only enhanced Stryker's offerings but also solidified its position as a leader in the market, consistently striving to improve surgical processes and patient care on a global scale.
Key Companies in the Minimally Invasive Surgery Devices Market Include:
- Conmed Corporation
- Stryker
- Intuitive Surgical
- Smith & Nephew
- Zimmer Biomet
- R. Bard
- Medtronic
- Karl Storz
- Braun Melsungen
- 55Fresenius SE & Co. KGaA
- Johnson & Johnson
- Olympus Corporation
- Abbott Laboratories
- Boston Scientific
Minimally Invasive Surgery Devices Market Developments
In order to facilitate difficult thoracic and urologic operations, Intuitive Surgical announced in February 2025 that it will introduce a next-generation da Vinci robotic system with improved tactile feedback and AI-assisted navigation.
Following prior FDA certification, CMR Surgical extended its Versius robotic platform across Latin America and Southeast Asia in March 2025 in response to the rising need for small, reasonably priced minimally invasive procedures. The FDA approved Johnson & Johnson's Ethicon division's powered laparoscopic stapler with integrated real-time tissue sensing in October 2024.
The device is intended to improve accuracy and lower intraoperative mistakes. The first 5 mm wristed, articulating laparoscopic tool line, the ArtiSential 5, was introduced by LivsMed in October 2024. Its finer instrumentation gives surgeons more maneuverability. The FDA approved Virtual Incision Corporation's MIRA mini-RAS system in February 2024.
It is a small robotic device for adult colectomy that integrates easily into current operating rooms. Furthermore, Momentis Surgical, founded in Israel, received FDA 510(k) approval in March 2025 for their Anovo single-port robotic device, which is intended to treat ventral hernias.
A significant step toward automation in gastrointestinal procedures was finally taken in February 2025 when state-of-the-art academic teams presented a semi-automated, contactless robot-assisted laser tissue soldering device for in-vivo colon incision closure in pigs.
Minimally Invasive Surgery Devices Market Segmentation Insights
Minimally Invasive Surgery Devices Market Application Outlook
- General Surgery
- Cardiothoracic Surgery
- Gynecological Surgery
- Urological Surgery
- Orthopedic Surgery
Minimally Invasive Surgery Devices Market Product Type Outlook
- Endoscopes
- Robotic Surgery Systems
- Laparoscopic Surgical Instruments
- Visualization Systems
- Access Devices
Minimally Invasive Surgery Devices Market End-use Outlook
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Minimally Invasive Surgery Devices Market Technology Outlook
- Video-Assisted Thoracoscopic Surgery
- Transcatheter Aortic Valve Replacement
- Natural Orifice Transluminal Endoscopic Surgery
Minimally Invasive Surgery Devices Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
34.09(USD Billion)
|
|
Market Size 2024
|
35.59(USD Billion)
|
|
Market Size 2035
|
57.2(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
4.41% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Conmed Corporation, Stryker, Intuitive Surgical, Smith & Nephew, Zimmer Biomet, C. R. Bard, Medtronic, Karl Storz, B. Braun Melsungen, 55Fresenius SE & Co. KGaA, Johnson & Johnson, Olympus Corporation, Abbott Laboratories, Boston Scientific
|
|
Segments Covered
|
Application, Product Type, End-use, Technology, Regional
|
|
Key Market Opportunities
|
Technological advancements in robotics, Increasing demand for outpatient procedures, Rising prevalence of chronic diseases, Expanding geriatric population, Growing preference for less invasive therapies
|
|
Key Market Dynamics
|
growing geriatric population, increasing demand for outpatient surgeries, technological advancements in devices, rising healthcare expenditure, increasing awareness of minimally invasive benefits
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Minimally Invasive Surgery Devices Market Highlights:
Frequently Asked Questions (FAQ) :
The Minimally Invasive Surgery Devices Market was valued at 35.59 USD billion in 2024.
By 2035, the market is projected to reach around 57.2 USD billion.
The market is expected to grow at a CAGR of 4.41% from 2025 to 2035.
The General Surgery segment dominated the market, valued at 10.5 USD billion in 2024 and projected to reach 16.25 USD billion by 2035.
The Cardiothoracic Surgery application was valued at 7.2 USD billion in 2024 and is projected to grow to 11.2 USD billion by 2035.
North America held the highest market value of 12.5 USD billion in 2024, expected to increase to 20.0 USD billion by 2035.
The Asia Pacific region held a market value of 8.0 USD billion in 2024.
The Urological Surgery application is projected to be valued at 8.5 USD billion by 2035.
Key players include Conmed Corporation, Stryker, Intuitive Surgical, and Johnson & Johnson among others.
The Orthopedic Surgery application was valued at 4.2 USD billion in 2024, with a projection of 9.75 USD billion by 2035.
